anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

190,081-190,140 of 319,975

filter-aware
22
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
23
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
24
Includes a comparison of Q2 2021 vs Q2 2022 and H1 2021 vs H1 2022.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
25
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
26
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
27
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
01
Slide 1
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations 1 hit
02
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations 1 hit
03
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations 1 hit
04
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations 1 hit
05
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations 1 hit
06
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
07
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
The slide uses a hub-and-spoke diagram to show data ingestion into a central AI platform, followed by a list of benefits.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
09
Includes a donut chart representing team composition and headshots of the board of directors.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
10
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
11
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
12
The slide uses two charts to demonstrate market validation: one for investment growth and one for pipeline expansion.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
13
The slide uses a before-after comparison structure to demonstrate the value of AI in pharma R&D.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
14
The slide uses a 2x2 matrix to map specific companies like BenevolentAI, Recursion, Exscientia, Schrodinger, and Relay Therapeutics.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
15
The slide uses a linear process flow (1. Data Foundations -> 2. AI Tools) with a circular feedback loop for the AI tools section.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
16
Uses a 2x2 matrix to represent the platform approach.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
17
The slide uses a comparison framework to highlight competitive advantages in drug discovery efficiency.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
18
The chart uses a horizontal bar format to compare IND filing rates against market capitalization for different tiers of pharma companies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
19
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
20
The slide uses a process flow diagram to illustrate the business model, combining a circular platform representation with a linear pipeline and branching commercial strategies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
21
The slide uses a hub-and-spoke style diagram to connect strategic pillars (Scientific, Commercial, Clinical, Data) to specific therapeutic area execution models.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
22
The slide uses a three-column layout to categorize validation types: Internal Pipeline, Strategic, and Clinical/Regulatory.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
23
The chart uses a timeline-style progression (Hit to Lead through Phase III) to visualize drug development status.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
24
The slide uses a split-layout with a dark-mode sidebar for AstraZeneca-specific details.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
25
The slide uses a list-based structure to demonstrate the value proposition and validation of the company's AI platform.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
26
Includes presenter name and title, and company logo.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
27
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
28
The slide uses a two-stage process flow: 1. Data Foundations (knowledge graph representation) and 2. AI Tools for Scientists (circular workflow).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
29
The slide illustrates a data integration pipeline from raw sources to a knowledge graph representation.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
30
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
31
The slide uses a process flow diagram to show how raw data inputs are transformed into structured knowledge.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
32
The slide uses a two-part process flow: data ingestion (left) and an iterative AI-driven research cycle (right).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
33
The slide uses a process flow diagram to map out the drug discovery pipeline, specifically focusing on the Target ID phase.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
34
The slide uses a vertical process flow on the left and a detailed 4-quadrant layout for the steps.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
35
The slide shows a process flow on the left (Tech Approach, Predict, Triage, TPA, Assay) and two screenshots of a software interface on the right.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
36
The slide shows a 'Triage Tool' interface. On the left is a process flow diagram (Tech Approach -> Predict -> Triage -> TPA -> Assay) with 'Triage' highlighted.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
37
The slide uses a vertical process flow on the left to indicate the current stage (TPA) within a larger drug discovery pipeline.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
38
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
39
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
40
Uses a circular diagram to represent the feedback loop between lab work and data integration.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
41
The chart uses a swimlane-style visualization to show progress across drug discovery stages (Target ID to Phase III).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
42
Includes a clinical photograph of the condition.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
43
Includes a biological mechanism diagram showing NGF, BDNF, and NTF-3 binding to TrkA, TrkB, and TrkC receptors.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
44
The slide uses a complex biological illustration to map specific receptor pathways to cellular mechanisms in AD skin.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
45
Includes data on T-cell activation inhibition, sensory neuron activation, and mouse ear inflammation reduction.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
46
The slide uses a process flow diagram to illustrate an adaptive clinical trial design.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
47
The slide uses a flow-chart to illustrate an adaptive clinical trial design.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
48
Includes specific caveats regarding small sample size and short duration.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
49
The slide outlines a clinical trial process flow with specific durations and patient ratios.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
50
The slide uses a visual treatment flow diagram to contrast current and future treatment options.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
51
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
52
Includes a process diagram for biopsy analysis and a market segmentation breakdown.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
53
The slide demonstrates the inhibitory effect of anti-TNF monoclonal antibodies on cytokine release.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
54
The slide displays protein phosphorylation intensity across various markers for healthy vs. inflamed tissue.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit